Business
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference call today at 5:00 pm ET to review results and provide operational updates LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective d
About this update from Vivos Therapeutics, Inc.
[{"type":"image","alt":"Vivos Therapeutics, Inc","displaySize":"","headline":null,"caption":"Vivos Therapeutics, Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":148,"height":46,"url":"https://media.zenfs.com/en/globenewswire.com/452f3e3cd3796a0ed8557400112a2519"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/o.bVqaj5F3NG9.btjYGvyg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTY1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/452f3e3cd3796a0ed8557400112a2519","width":148,"height":46}},"lazy":false},{"type":"text","content":"Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations","length":166,"tagName":"p"},{"type":"text","content":"Management to host conference call today at 5:00 pm ET to review results and provide operational updates","length":104,"tagName":"p"},{"type":"text","content":"LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective diagnostic procedures and proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults and moderate to severe OSA in children), today reported financial results and operating highlights for the three and nine months ended September 30, 2025.","length":537,"tagName":"p"},{"type":"text","content":"Kirk Huntsman, Vivos’ Chairman and Chief Executive Officer, stated, “We are very pleased to announce that our third quarter sequential revenue was up 78%, while same period year-over-year revenue increased 76%. This outstanding quarterly revenue increase represents exactly what we anticipated when we announced and executed our strategic pivot away from our historical reliance on a dental industry distribution channel and toward a direct affiliation with, or acquisition of, medical sleep practices and testing centers. This pivot was showcased by our June 2025 acquisition of The Sleep Center of Nevada (SCN).”","length":614,"tagName":"p"},{"type":"text","content":"“Importantly, these results highlight the impact of our first full quarter of operations since our SCN acquisition,” continued Mr. Huntsman. “Even at this early stage, we are seeing the ben...